Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2019-10-24 | 2020-02-13 | 97156 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-01-09 | 2020-03-05 | 102914 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2020-01-30 | 2020-03-19 | 104905 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-02-13 | 2020-02-21 | 106012 |
| TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-06-04 | 2020-07-09 | 116675 |
| TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-06-25 | 2020-08-21 | 118909 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-07-23 | 2020-08-21 | 120887 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2020-08-20 | 2020-10-08 | 122705 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2020-09-24 | 2020-10-08 | 124989 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-11-06 | 2020-11-12 | 128019 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2021-01-07 | 2021-02-18 | 131075 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-01-07 | 2021-02-25 | 131084 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-02-18 | 2021-03-04 | 134337 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-03-11 | 2021-03-25 | 135567 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-03-11 | 2021-03-18 | 135570 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-10-07 | 2021-11-11 | 146853 |
| TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2022-04-21 | 2022-08-20 | 159210 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2022-11-14 | 2023-02-02 | 174604 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2022-12-22 | 2023-04-28 | 179297 |
| TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2023-04-27 | 2023-06-21 | 190686 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |